None listed
Conditions
Brief summary
This study investigates the analgesic effect of intraperitoneal injection of a long acting local anaesthetic agent (Ropivacaine) during laparoscopic (keyhole) appendicectomy. Trial participants will be randomly divided into two groups. One group will receive intraperitoneal Ropivacaine during laparoscopic appendicectomy while the other will receive normal saline. The consumption quantity of total Fentanyl analgesia, the presence of shoulder tip pain and post surgery nausea or vomiting will be recorded up to 16 hours post surgery. The study aims to determine whether the use of Ropivacaine during laparoscopic appendectomy is an useful analgesic adjunct. The primary aim of this study will be to determine whether using Ropivacaine will reduce total amount of analgesia used, hence reducing post-operative pain, and its effect on the incidence of post laparoscopic appendicectomy shoulder tip pain and nausea or vomiting.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
All patients undergoing laparoscopic appendicectomy at Armadale Hospital
Exclusion criteria
1. Medical or psychiatric conditions that compromise patient’s ability to give informed consent 2. Pregnant or breast feeding 3. Allergies to paracetamol, fentanyl or ropivacaine. 4. Liver failure 5. Conversion from laparoscopic surgery to open surgery 6. Presence of faecal peritonitis 7. ASA III 8. Iatrogenic perforation 9. Chronic pain syndrome 10. Operative time more than 2 hours. 11. Drain insertion 12. Weight >100kg